SinoPharm
In coronavirus vaccine race, China inoculates thousands before trials are completed
Vaccine safety came into sharp focus last week when AstraZeneca Plc paused late-stage clinical trials of its COVID-19 vaccine
China shows off homegrown COVID-19 vaccines for first time
The potential vaccines on display are among nearly 10 worldwide to enter phase 3 trials, the last step ahead of regulatory approval
Russia to mass-produce its experimental COVID-19 vaccine
The first human trial of the vaccine, a month-long test on 38 people, ended this week, and Phase III trial is set to begin in August
Chinese firm SinoPharm boasts about using workers to 'pre-test' vaccine
The company’s claim that 30 ‘special volunteers’ rolled up their sleeves for pre-test without a government approval raises ethical concerns
1 of 1